• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about CYBN

    Recent news which mentions CYBN

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Tickers ATAI CMND CMPS CYBN
    Tags IXHL News Penny Stocks
    From Benzinga
    30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond
    Tickers CYBN ENVB NEWS NUMIF
    Tags Biotech Psychedelics Investing Market News
    From Benzinga
    Cybin Inc's Two Deuterated Psychedelic Molecules Achieve Positive Topline Clinical Results
    Tickers CYBN NEWS
    Tags Global Market News Deuterated Psychedelics
    From Benzinga
    Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD
    Tickers ATAI CMPS CYBN DMTTF
    Tags CYBN CMPS MDMA
    From Benzinga
    Psychedelic Stock Gainers And Losers From January 1, 2024
    Tickers ATAI CMPS CYBN GHRS
    Tags Benzinga ATAI Markets
    From Benzinga
    Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
    Tickers BIIB CYBN SUPN
    Tags NYSE:CYBN,NASDAQ:SUPN,NASDAQ:BIIB SUPN CYBN
    From InvestorPlace
    Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
    Tickers ATAI CMND CMPS CYBN
    Tags GHRS Ketamine Treatment Cannabis
    From Benzinga
    Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
    Tickers CYBN
    Tags Markets Psychedelic/Assisted Therapies News
    From Benzinga
    Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
    Tickers ATAI AWKNF CMPS CYBN
    Tags IXHL Psychedelic/Assisted Therapies MNMD
    From Benzinga
    GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
    Tickers ATAI CMPS CYBN GHRS
    Tags Market News GHRS Cannabis
    From Benzinga
    Analyst Expectations for Cybin's Future
    Tickers CYBN
    Tags Market News Analyst Ratings CYBN
    From Benzinga
    Expedia To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Friday
    Tickers A ADI CMAX CYBN
    Tags Markets PT Changes HUBB
    From Benzinga
    Cybin Reports Access To $101M To Sustain Deuterated Psychedelics Programs, Q2 Numbers & 2024 Goals
    Tickers CYBN
    Tags CYBN Cannabis Market News
    From Benzinga
    Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
    Tickers ATAI CMPS CYBN DRUG
    Tags CMPS CYBN Events
    From Benzinga
    Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
    Tickers CYBN
    Tags News Benzinga Penny Stocks
    From Benzinga
    Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
    Tickers ATAI CMPS CYBN DEA
    Tags Market News HUGE DRUG
    From Benzinga
    Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
    Tickers CYBN
    Tags Market News major depressive disorder Psilocybin program
    From Benzinga
    Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Small Cap DMTTF News
    From Benzinga
    Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
    Tickers CYBN DMTTF
    Tags Benzinga News DMTTF
    From Benzinga
    Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
    Tickers CYBN DMTTF
    Tags M&A Market News Psychedelics
    From Benzinga
    Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
    Tickers ATAI CMPS CYBN DMTTF
    Tags Market News Dr/ Roland Griffiths HUGE
    From Benzinga
    Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
    Tickers CYBN DMT DMTTF
    Tags M&A Market News DMTTF
    From Benzinga
    Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement
    Tickers CYBN DMTTF
    Tags share transaction Contracts CYBN
    From Benzinga
    Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Marianne Williamson CYBN CMPS
    From Benzinga
    Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
    Tickers CYBN DMTTF
    Tags DMTTF News Benzinga
    From Benzinga
    Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
    Tickers ATAI BNOX CMPS CYBN
    Tags Market News HUGE week roundup
    From Benzinga
    Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
    Tickers CYBN
    Tags major depressive disorder Deuterated Psychedelics Market News
    From Benzinga
    Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
    Tickers BNOX CYBN MRK
    Tags Point72 Asset Management Market News BNOX
    From Benzinga
    Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
    Tickers ATAI CMPS CYBN DMTTF
    Tags Psychedelics Reform DRUG Penny Stocks
    From Benzinga
    Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
    Tickers CYBN
    Tags Benzinga News Fluence
    From Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.